United States · FDA National Drug Code directory

Lorazepam

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-228_08a911c9-3b1b-4404-a770-5bf4d27c7e96
Product NDC
71205-228
Form
TABLET
Composition / generic term
Lorazepam
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20170324
Source listing expiry
20261231

Source-listed ingredients

  • LORAZEPAM — .5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 2 TABLET in 1 BOTTLE (71205-228-02) · 71205-228-02
  • 3 TABLET in 1 BOTTLE (71205-228-03) · 71205-228-03
  • 15 TABLET in 1 BOTTLE (71205-228-15) · 71205-228-15
  • 20 TABLET in 1 BOTTLE (71205-228-20) · 71205-228-20
  • 30 TABLET in 1 BOTTLE (71205-228-30) · 71205-228-30
  • 60 TABLET in 1 BOTTLE (71205-228-60) · 71205-228-60
  • 90 TABLET in 1 BOTTLE (71205-228-90) · 71205-228-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →